The proposed rule amendment is intended to clarify the renewal fees for resident physicians, assistant resident physicians, interns and fellows.

 

DEPARTMENT OF HEALTH

Board of Medicine

RULE NO.:RULE TITLE:

64B8-3.003Renewal Fees

PURPOSE AND EFFECT: The proposed rule amendment is intended to clarify the renewal fees for resident physicians, assistant resident physicians, interns and fellows.

SUMMARY: The proposed rule amendments clarify the correct statutory renewal fees for resident physicians, assistant resident physicians, interns and fellows.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION: The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature because the clarification of the fee actually reflects a lower fee than that currently set forth in the rule as it is currently written. The proposed rule amendment will not in any way increase personnel costs, it will not result in decreased profit opportunities, and will not require any specialized knowledge to comply. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 456.025, 458.309(1), 458.311, 458.3115, 458.3124, 458.313, 458.3145, 458.315, 458.316, 458.3165, 458.317, 458.319, 458.345 FS.

LAW IMPLEMENTED: 456.025(1), 456.036(3), 458.319(1), 458.345(4) FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: André Ourso, J.D., M.P.H., Executive Director, Board of Medicine/MQA, 4052 Bald Cypress Way, Bin #C03, Tallahassee, Florida 32399-3253

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B8-3.003 Renewal Fees.

(1) No change.

(2) The following renewal fees are prescribed by the Board:

(a) Biennial renewal fee for physicians licensed pursuant to Sections 458.311, 458.3115, 458.3124, and 458.313, F.S., for physicians holding a limited license; and for physicians holding a medical faculty certificate as a distinguished medical scholar, a temporary certificate for practice in areas of critical need, a public psychiatry certificate, or a public health certificate shall be $360.00. However the following exceptions shall apply:

1. through 2. No change.

3. For resident physicians, assistant resident physicians, fellows, and interns licensed pursuant to Sections 458.311, 458.3115, 458.3124, and 458.313, F.S., in an approved postgraduate training program, the biennal renewal fee shall be $200.00, pursuant to Section 458.319(1), F.S. If the licensee is either a resident physician, assistant resident physician, fellow, or intern in an approved postgraduate training program, the biennial renewal fee shall be $220.00.

4. through 5. No change.

(b) Resident physicians, assistant resident physicians, interns, and fellows in fellowship training registered pursuant to Section 458.345, F.S., shall be exempt from the biennial renewal fee, pursuant to Section 458.345(4), F.S.

(c) (b) Biennial renewal fee for a person registered as a house physician pursuant to Section 458.345, F.S., shall be $220.00.

Rulemaking Authority 456.025, 458.309(1), 456.036(3), 458.311, 458.3115, 458.3124, 458.313, 458.3145, 458.315, 458.316, 458.3165, 458.317, 458.319, 458.345 FS. Law Implemented 456.025(1), 456.036(3), 456.317(4), 458.319(1), 458.345(4) FS. History–New 12-5-79, Amended 10-24-85, Formerly 21M-19.03, Amended 12-4-86, 11-3-87, 5-24-88, 11-15-88, 11-12-89, 1-9-92, Formerly 21M-19.003, Amended 9-21-93, 4-14-94, Formerly 61F6-19.003, Amended 10-10-95, 6-24-96, 1-26-97, Formerly 59R-3.003, Amended 6-7-98, 8-11-98, 12-14-99, 10-30-01, 3-25-02, 10-19-03, 12-2-03, 7-2-07, 7-22-14,__________.

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Rules Committee, Board of Medicine

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Medicine

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: December 5, 2014

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: December 23, 2014